MTCH2 and viral infectious disease: All constructs were overexpressed in HEK293T cells to assess MTCH2-CPT1 interaction, and were subsequently introduced into iBAs via viral infection, followed by siRNA-mediated knockdown of endogenous MTCH2 to evaluate their effects on CPT1 activity.